卫生研究优先领域设置报告规范——REPRISE指南解读  

Interpretation of the REPRISE guideline:a reporting guideline for priority setting of health research

作　　者：景城阳 张乐 吴雪 赵琨 廖星[1] JING Chengyang;ZHANG Le;WU Xue;ZHAO Kun;LIAO Xing(Center for Evidence Based Chinese Medicine,Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,P.R.China;Wanke Public Health School,Tsinghua University,Beijing 100084,P.R.China)

机构地区：[1]中国中医科学院中医临床基础医学研究所,循证医学基础研究室,北京100700 [2]清华大学万科公共卫生与健康学院,北京100084

出　　处：《中国循证医学杂志》2023年第1期99-104,共6页Chinese Journal of Evidence-based Medicine

基　　金：国家自然科学基金项目(编号:82174239);中国中医科学院科技创新工程项目(编号:CI2021A05503、CI2021A00701-3)。

摘　　要：随着有限卫生资源与人口不断增长之间的矛盾日渐凸显,卫生研究优先领域设置作为一种应对之策,受到全球范围内卫生系统的广泛关注。随着不同层级的优先领域设置研究结果逐年增多,研究结果报告方面的问题亦不断显现。例如对结果的产生过程报告不清楚、过于依赖个人主观判断、个别利益相关群体的参与程度有限或缺少话语权、无法明确潜在的利益冲突等。这不仅严重影响了研究结果自身的有效性与合理性,更对其推广、采纳产生了无形障碍。2019年BMC Medical Research Methodology发表了《卫生研究优先领域设置报告规范(REPRISE)》,即REPRISE指南,为促成更为全面、一致的优先领域研究报告做了统一规范。本文就REPRISE指南的背景、制订过程、重点内容进行解读,以期促进该报告规范在中国的推广应用。With the increasingly prominent contradiction between limited health resources and the growing population,priority setting of health research,as a response,has received widespread attention from health systems worldwide.As the results of priority setting at different levels increase year by year,some questions in the results reporting are also constantly emerging.For example,the process of producing the results is vague,too dependent on individual subjective judgment,the participation of individual stakeholder groups is limited or lack of voice,unable to identify potential conflicts of interest,and so on.It does not only seriously affect the effectiveness and rationality of the results themselves,but also create intangible obstacles to their promotion and adoption.In 2019,BMC Medical Research Methodology published’Reporting guideline for priority setting of health research(REPRISE)’,which makes uniform specifications for more comprehensive and consistent reporting of results in priority areas.This paper interpreted the background,formulation process and key contents of the REPRISE guideline,with an aim to promote the application of the reporting guideline in China.

关 键 词：卫生研究 优先领域设置 REPRISE指南 报告规范 

分 类 号：R197[医药卫生—卫生事业管理]